Schittenhelm Jens, Tabatabai Ghazaleh, Sipos Bence
Department of Neuropathology, University Medical Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Interdisciplinary Division of Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Medical Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Histol Histopathol. 2016 Oct;31(10):1069-78. doi: 10.14670/HH-11-7741. Epub 2016 Apr 14.
The tumor environment plays an integral part in the biology of cancer, participating in tumor initiation, progression, and response to therapy. Integrins, a family of cell surface receptors, bridge the extracellular matrix to the intracellular cytoskeleton. Since their first characterization 25 years ago, a vast amount of work has been performed to understand the essential role of integrins in cell development, tissue organization, tumor growth, vessel development and their signaling mechanisms. Their potential as therapeutic targets in various types of cancer is intensively studied. In this review, we discuss the expression patterns and functional role of integrin in primary brain tumors and brain metastases, provide an overview of clinical data on integrin inhibition and their potential application in imaging and therapy of these tumors.
肿瘤微环境在癌症生物学中起着不可或缺的作用,参与肿瘤的起始、进展以及对治疗的反应。整合素是一类细胞表面受体家族,它将细胞外基质与细胞内细胞骨架连接起来。自25年前首次被鉴定以来,人们开展了大量工作来了解整合素在细胞发育、组织构建、肿瘤生长、血管发育及其信号传导机制中的重要作用。人们深入研究了它们作为各类癌症治疗靶点的潜力。在本综述中,我们讨论了整合素在原发性脑肿瘤和脑转移瘤中的表达模式和功能作用,概述了整合素抑制的临床数据及其在这些肿瘤成像和治疗中的潜在应用。